Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)
The purpose of this notice of funding opportunity (NOFO) is to support innovative basic, clinical, translational, and implementation science research relevant to HIV and substance use. Offered by National Institutes of Health; applications due September 25, 2028.
Key Facts
- Funder
- National Institutes of Health
- Award amount
- Not specified by funder
- Deadline
- September 25, 2028
- Geography
- United States
- Categories
- Research
- Status
- Open
About This Grant
The purpose of this notice of funding opportunity (NOFO) is to support innovative basic, clinical, translational, and implementation science research relevant to HIV and substance use. This initiative encourages high risk high impact transformative studies that advance knowledge and strategies for HIV prevention, diagnosis, treatment and virus suppression in people who use substances and/or have a substance use disorder.
Full requirements and application instructions: official listing.
Similar Open Grants
Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed)
National Institutes of Health
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
National Institutes of Health
Translational Neural Devices (R61/R33 - Clinical Trial Optional)
National Institutes of Health
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)
National Institutes of Health
NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)
National Institutes of Health
Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)
National Institutes of Health
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
National Institutes of Health
Limited Competition: Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)
National Institutes of Health
NIGMS Institutional Biomedical Undergraduate Research Training (BURT) Program (T34)
National Institutes of Health
Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)
National Institutes of Health